Last edition
News about "CDMOs"
Biodeal Pharmaceuticals Secures INR 385 Crore Growth Investment from RMB Capitalworks
Biodeal Pharmaceuticals raises INR 385 crore from RMB Capitalworks to accelerate specialty pharma expansion, strengthen manufacturing capabilities and expand its presence across global regulated markets.
CDMOs | 11/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members